Ordering Recommendation

Screen for mast cell activation disorders.

Mnemonic
BETA PG U
Methodology

Quantitative Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)

Performed

Varies

Reported

3-9 days

New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation

Patients taking aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) may have decreased concentrations of prostaglandin F2 alpha. If possible, discontinue for 2 weeks or 72 hours, respectively, prior to collecting a specimen.

Collect

24 hour urine. Also acceptable: Random urine collection.

Specimen Preparation

Refrigerate specimen during collection. Transfer 4 mL urine to an ARUP Standard Transport Tube. (Min: 3 mL)

Storage/Transport Temperature

Refrigerated. Also acceptable: Frozen.

Unacceptable Conditions
Remarks
Stability

Ambient: 8 hours; Refrigerated: 2 weeks; Frozen: 1 month

Reference Interval

By Report

Interpretive Data



Compliance Category

Performed by non-ARUP Laboratory

Note
Hotline History
N/A
CPT Codes

84150

Components
Component Test Code* Component Chart Name LOINC
3002338 2,3 Dinor-11Beta-Prostaglandin F2, Urine 94381-1
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • 11 Beta-Prostaglandin F2 Alpha
  • 11BPG
  • 2, 3 11 Beta-Prostaglandin F2 Alpha
  • 23BPG
  • BPG2
  • Mastocytosis
  • Prostaglandin
2,3 Dinor-11Beta-Prostaglandin F2 Alpha, Urine

Mayo Clinic Laboratories